253 related articles for article (PubMed ID: 24288679)
1. Human induced pluripotent stem cells from basic research to potential clinical applications in cancer.
Fernandez Tde S; de Souza Fernandez C; Mencalha AL
Biomed Res Int; 2013; 2013():430290. PubMed ID: 24288679
[TBL] [Abstract][Full Text] [Related]
2. Aurora-A overexpression is linked to development of aggressive teratomas derived from human iPS cells.
Ohmine S; Salisbury JL; Ingle J; Pettinato G; Haddox CL; Haddad T; Galanis E; Ikeda Y; D'assoro AB
Oncol Rep; 2018 Apr; 39(4):1725-1730. PubMed ID: 29393405
[TBL] [Abstract][Full Text] [Related]
3. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation dynamics in human induced pluripotent stem cells.
Nishino K; Umezawa A
Hum Cell; 2016 Jul; 29(3):97-100. PubMed ID: 27083573
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
6. Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies.
Pratumkaew P; Issaragrisil S; Luanpitpong S
Cells; 2021 Nov; 10(11):. PubMed ID: 34831472
[TBL] [Abstract][Full Text] [Related]
7. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
[TBL] [Abstract][Full Text] [Related]
8. New frontier in regenerative medicine: site-specific gene correction in patient-specific induced pluripotent stem cells.
Garate Z; Davis BR; Quintana-Bustamante O; Segovia JC
Hum Gene Ther; 2013 Jun; 24(6):571-83. PubMed ID: 23675640
[TBL] [Abstract][Full Text] [Related]
9. Human induced pluripotent stem cell and nanotechnology-based therapeutics.
Liu WH; Chang YL; Lo WL; Li HY; Hsiao CW; Peng CH; Chiou SH; Ma HI; Chen SJ
Cell Transplant; 2015; 24(11):2185-95. PubMed ID: 25299513
[TBL] [Abstract][Full Text] [Related]
10. Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells.
Ruiz S; Diep D; Gore A; Panopoulos AD; Montserrat N; Plongthongkum N; Kumar S; Fung HL; Giorgetti A; Bilic J; Batchelder EM; Zaehres H; Kan NG; Schöler HR; Mercola M; Zhang K; Izpisua Belmonte JC
Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16196-201. PubMed ID: 22991473
[TBL] [Abstract][Full Text] [Related]
11. Human-Induced Pluripotent Stem Cell Technology and Cardiomyocyte Generation: Progress and Clinical Applications.
Di Baldassarre A; Cimetta E; Bollini S; Gaggi G; Ghinassi B
Cells; 2018 May; 7(6):. PubMed ID: 29799480
[TBL] [Abstract][Full Text] [Related]
12. Who Will Win: Induced Pluripotent Stem Cells Versus Embryonic Stem Cells for β Cell Replacement and Diabetes Disease Modeling?
Jacobson EF; Tzanakakis ES
Curr Diab Rep; 2018 Oct; 18(12):133. PubMed ID: 30343423
[TBL] [Abstract][Full Text] [Related]
13. Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery.
De Masi C; Spitalieri P; Murdocca M; Novelli G; Sangiuolo F
Hum Genomics; 2020 Jun; 14(1):25. PubMed ID: 32591003
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine.
Walia B; Satija N; Tripathi RP; Gangenahalli GU
Stem Cell Rev Rep; 2012 Mar; 8(1):100-15. PubMed ID: 21671061
[TBL] [Abstract][Full Text] [Related]
15. Human-Induced Pluripotent Stem Cells in Plastic and Reconstructive Surgery.
Hadzimustafic N; D'Elia A; Shamoun V; Haykal S
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339142
[TBL] [Abstract][Full Text] [Related]
16. Short-term retinoic acid treatment sustains pluripotency and suppresses differentiation of human induced pluripotent stem cells.
De Angelis MT; Parrotta EI; Santamaria G; Cuda G
Cell Death Dis; 2018 Jan; 9(1):6. PubMed ID: 29305588
[TBL] [Abstract][Full Text] [Related]
17. Electrospun polystyrene scaffolds as a synthetic substrate for xeno-free expansion and differentiation of human induced pluripotent stem cells.
Leong MF; Lu HF; Lim TC; Du C; Ma NKL; Wan ACA
Acta Biomater; 2016 Dec; 46():266-277. PubMed ID: 27667015
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms underlying the formation of induced pluripotent stem cells.
González F; Huangfu D
Wiley Interdiscip Rev Dev Biol; 2016; 5(1):39-65. PubMed ID: 26383234
[TBL] [Abstract][Full Text] [Related]
19. The translational potential of human induced pluripotent stem cells for clinical neurology : The translational potential of hiPSCs in neurology.
Devine H; Patani R
Cell Biol Toxicol; 2017 Apr; 33(2):129-144. PubMed ID: 27915387
[TBL] [Abstract][Full Text] [Related]
20. Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.
Hayashi Y; Chan T; Warashina M; Fukuda M; Ariizumi T; Okabayashi K; Takayama N; Otsu M; Eto K; Furue MK; Michiue T; Ohnuma K; Nakauchi H; Asashima M
PLoS One; 2010 Nov; 5(11):e14099. PubMed ID: 21124894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
